The world once again will spend time talking about Diabetes on World Diabetes Day (November 14th). As we all encourage each other to get tested ...

One man’s story of recovery from diabetes, and how the community can help on the way, has been added to a health awareness ...

We are living in exciting times regarding therapies for people with diabetes. Much of the excitement ... precise regulatory guidance will still be needed for discussion and decision making about ...

While an FDA advisory committee saw signals of efficacy for Lexicon Pharmaceuticals’ sotagliflozin, the panel of external ...

Insulet (Nasdaq:PODD) today announced its plans to recognize National Diabetes Awareness Month and World Diabetes Day.

According to a CNN report on Sunday (Nov. 10), recent discussions about Supreme Court Justice Sonia Sotomayor's potential ...

MONTANA - Diabetes is a widespread issue throughout the United States, and Montana is no exception. According to the American ...

Lexicon did manage to get approval for type 1 diabetes in Europe, but the product was never launched there for commercial ...

The time is now to align on a shared plan of action as a country to achieve diversity, equity, inclusion, and access in US ...

Lexicon Pharmaceuticals received a negative vote from a Food and Drug Administration advisory committee for Zynquista as an adjunct to insulin therapy for glycemic control in adults with Type 1 ...

The FDA panel voted against the approval of sotagliflozin for patients with type 1 diabetes and chronic kidney disease.

Certain GLP-1 medications, like Ozempic, are only FDA-approved for type 2 diabetes, and others ... But sports and nutrition experts say an honest discussion about the drugs’ potential impact in the ...